How is an infant under 8 months old with Kawasaki disease and Reye's syndrome treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of an Infant Under 8 Months with Kawasaki Disease and Reye's Syndrome

Critical Management Decision

In an infant under 8 months presenting with both Kawasaki disease and Reye's syndrome, aspirin must be immediately discontinued and IVIG 2 g/kg should be administered as a single infusion without aspirin, while managing Reye's syndrome with supportive intensive care. 1

Immediate Actions for Dual Diagnosis

Discontinue Aspirin Immediately

  • Stop all salicylate therapy immediately upon recognition of Reye's syndrome, as aspirin is a known contributing factor to this metabolic disorder 1, 2
  • Reye's syndrome has been documented in infants as young as 7-10 months receiving high-dose aspirin for Kawasaki disease, with rapid progression to hepatic failure and encephalopathy 2, 3

Administer IVIG Without Aspirin

  • Proceed with IVIG 2 g/kg as a single infusion over 10-12 hours as the primary treatment for Kawasaki disease, which remains effective without concurrent aspirin therapy 1, 4
  • The American Heart Association explicitly addresses this scenario, recommending IVIG administration without aspirin when influenza or other viral infections complicate Kawasaki disease 1

Intensive Care Management for Reye's Syndrome

  • Transfer to intensive care unit for management of hepatic encephalopathy, coagulopathy, and hyperammonemia 2, 3
  • Monitor for hypoglycemia, elevated transaminases (AST/ALT), prolonged PT/PTT, and elevated ammonia levels 2, 3
  • Provide supportive care including glucose supplementation, correction of coagulopathy, and management of increased intracranial pressure 2, 3

Alternative Antipyretic and Antiplatelet Strategy

Fever Management

  • Use acetaminophen as the alternative antipyretic during the acute phase instead of aspirin 1
  • Continue acetaminophen until fever resolves for 48-72 hours 1

Antiplatelet Therapy After Reye's Syndrome Resolution

  • Substitute an alternative antiplatelet agent for a minimum of 2 weeks once Reye's syndrome resolves and if antiplatelet therapy is needed 1
  • Consider clopidogrel as the alternative antiplatelet agent if coronary abnormalities develop 5, 4
  • Do not resume aspirin therapy until the infant has fully recovered from Reye's syndrome and viral illness has completely resolved 1

Cardiac Monitoring Protocol

Echocardiographic Surveillance

  • Perform echocardiography at diagnosis, 2 weeks, and 6-8 weeks after treatment initiation 4
  • Infants under 1 year have the highest risk of coronary artery aneurysms, making aggressive monitoring essential 4, 6

Long-Term Anticoagulation Based on Coronary Status

  • If no coronary abnormalities develop by 6-8 weeks, discontinue antiplatelet therapy entirely 1, 4
  • If coronary abnormalities develop, continue alternative antiplatelet agent (clopidogrel) indefinitely rather than aspirin given the history of Reye's syndrome 1, 4
  • For giant aneurysms (≥8 mm), add warfarin with target INR 2.0-3.0 or low molecular weight heparin 5, 4

Critical Pitfalls to Avoid

Do Not Resume Aspirin Prematurely

  • Never restart aspirin while any viral illness symptoms persist or within 2 weeks of Reye's syndrome diagnosis, as recurrence risk remains elevated 1, 7
  • The mortality rate from Reye's syndrome in infants can be extremely high (case reports document death within 2 days despite intensive care) 3

Do Not Delay IVIG Waiting for Aspirin

  • IVIG alone is effective for preventing coronary artery abnormalities; aspirin does not reduce coronary complications and serves only as adjunctive anti-inflammatory and antiplatelet therapy 1, 4
  • Delaying IVIG to address aspirin concerns increases risk of coronary artery aneurysms, which occur in 20-25% of untreated patients 6

Recognize Reye's Syndrome Early

  • In infants, Reye's syndrome may present more subtly with diarrhea, respiratory disturbances, and seizures rather than the classic protracted vomiting seen in older children 8
  • Symptoms typically develop 3-5 days after aspirin initiation, just when the child appears to be recovering from the acute illness 8, 3

Future Prevention Strategies

Influenza Vaccination

  • Once the infant reaches 6 months of age and recovers, administer annual inactivated influenza vaccine to prevent future viral triggers for Reye's syndrome 1, 7, 4
  • Vaccinate all family members to reduce household transmission risk 1, 4

Parental Education

  • Instruct parents to contact physician immediately if the child develops symptoms of or exposure to influenza or varicella in the future 1, 7
  • Educate about the absolute contraindication to aspirin and other salicylates during any viral illness 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reye's syndrome developing in an infant on treatment of Kawasaki syndrome.

Journal of paediatrics and child health, 2005

Research

Kawasaki disease with Reye syndrome: report of one case.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui, 1992

Guideline

Kawasaki Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of IVIG-Resistant Kawasaki Disease with Cardiac Involvement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Kawasaki disease].

Anais brasileiros de dermatologia, 2009

Guideline

Monitoring for Reye's Syndrome in Infants on High-Dose Aspirin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Reye's syndrome: an update.

The Nurse practitioner, 1997

Related Questions

What is Reye's syndrome, its detection, and treatment in an infant under 8 months old with Kawasaki disease being treated with high-dose aspirin (acetylsalicylic acid)?
Is Reye's syndrome a risk when administering high-dose aspirin (acetylsalicylic acid) to an infant less than 8 months old with Kawasaki disease?
What is the treatment and prevention of Reyes syndrome in children and teenagers?
What is the pathophysiology of Reye's syndrome in an infant under 8 months old with Kawasaki disease, treated with aspirin (acetylsalicylic acid)?
What is the management and prevention of Reye's syndrome?
What is the best course of management for a patient with a 2.9 x 2.6 x 1.8 cm septated cyst and normal flow?
Does a healthy 29-year-old without a history of asthma or allergies have an increased risk of developing allergic asthmatic reactions after intubation?
Can an adult patient with a history of anxiety or depression, who experienced a failed dose increase, rely on the effectiveness and stability of 52 mg of escitalopram (an SSRI) after 7 days?
What is the first step in the current asthma treatment algorithm for a 29-year-old healthy individual without a prior history of asthma or allergies, experiencing respiratory symptoms post-intubation?
What is the role of lactoferrin in managing high Low-Density Lipoprotein (LDL) cholesterol levels in patients with a history of cardiovascular disease?
How likely is it that the patient with Obsessive-Compulsive Disorder (OCD) will return to stability on 52mg of escitalopram (SSRI) after the incorrect dose increase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.